Seasonal influenza: an overview.

@article{Li2009SeasonalIA,
  title={Seasonal influenza: an overview.},
  author={Christina Li and Marian Freedman},
  journal={The Journal of school nursing : the official publication of the National Association of School Nurses},
  year={2009},
  volume={25 Suppl 1},
  pages={
          4S-12S
        }
}
  • Christina LiM. Freedman
  • Published 1 February 2009
  • Medicine
  • The Journal of school nursing : the official publication of the National Association of School Nurses
Seasonal influenza is a major cause of morbidity and mortality in the United States. It also has major social and economic consequences in the form of high rates of absenteeism from school and work as well as significant treatment and hospitalization costs. In fact, annual influenza epidemics and the resulting deaths and lost days of productivity are estimated to cost US$10.4 billion in direct medical expenses and US$16.4 billion in lost potential earnings. Given the enormous burden of seasonal… 

Epidemiologic and Economic Burden of Influenza in the Outpatient Setting: A Prospective Study in a Subtropical Area of China

Children aged <5 years were the most-affected population, suffering from influenza at the highest rates, and the medical costs per episode of influenza among urban patients were higher than those for rural patients.

Are we still afraid of influenza during the Sars-Cov2 pandemic? - epidemiological analysis of influenza morbidity and vaccination in the 2019/2020 season

A closer look at the numerical values of people with influenza is taken and the possible causes of this decline are discussed, including the Covid-19 pandemic, which affected the incidence of another virus, such as the influenza virus, and cause its decline.

Influenza Surveillance among Outpatients and Inpatients in Morocco, 1996–2009

Influenza results in both mild and severe respiratory infections in Morocco, and accounted for a large proportion of all hospitalizations for severe respiratory illness among children 5 years of age and younger.

Incidence of Guillain-Barré Syndrome Is Not Associated with Influenza Vaccination in the Elderly

While GBS can potentially develop from various infections, no association was found between GBS and IV and these results will contribute to developing an evidence-based vaccine policy that includes a clear causality assessment of adverse events.

Dynamic patterns of circulating influenza virus from 2005 to 2012 in Shandong Province, China

The Shandong Provincial influenza surveillance system was sensitive in detecting influenza virus variability by season and by genetic composition, which will help official public health target interventions such as education programs and vaccines.

Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials.

NIs seem to be effective in reducing total influenza-related complications in otherwise healthy and high-risk patients, and have an acceptable safety profile, however, RCTs providing separate data for mild to serious complications and detailed reporting of adverse events and mortality are needed.

School-Located Vaccination Clinics: Then and Now

  • D. Mazyck
  • Medicine, Political Science
    The Journal of school nursing : the official publication of the National Association of School Nurses
  • 2010
School-located vaccination has a long history in the United States, but the ability to administer this vast number of vaccinations may be beyond the capacity of primary care providers, leaving schools as an attractive venue for mass immunization clinics.

Ready or not? Protecting the public's health from diseases, disasters, and bioterrorism.

  • L. WeickerC. Harris
  • History
    Biosecurity and bioterrorism : biodefense strategy, practice, and science
  • 2009
TFAH thanks the reviewers for their time, expertise, and insights. The opinions expressed in this report do not necessarily represent the views of these individuals or their organizations.

Effect of the β-propiolactone treatment on the adsorption and fusion of influenza A/Brisbane/59/2007 and A/New Caledonia/20/1999 virus H1N1 on a dimyristoylphosphatidylcholine/ganglioside GM3 mixed phospholipids monolayer at the air-water interface.

The production protocol of many whole cell/virion vaccines involves an inactivation step with β-propiolactone (BPL). Despite the widespread use of BPL, its mechanism of action is poorly understood.